Slo2 and Slo4, novel potassium channel proteins from human brain

Details for Australian Patent Application No. 2001284995 (hide)

Owner ICAgen, Inc

Inventors Witzel, Julie Dickson; Jegla, Timothy James

Agent FB Rice

Pub. Number AU-B-2001284995

PCT Pub. Number WO02/40649

Priority 60/249,112 15.11.00 US; 09/921,159 01.08.01 US

Filing date 15 August 2001

Wipo publication date 27 May 2002

Acceptance publication date 29 March 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

29 March 2007 Application Accepted

  Published as AU-B-2001284995

13 September 2007 Section 223 Application Allowed

  ICAgen, Inc The time in which to pay the acceptance fee has been extended to 29 Jul 2007. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 Extensions of Time, Section 223

20 September 2007 Standard Patent Sealed

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001284996

2001284994